How does CPC compare to Wuhan Wansheng Biotechnology on documentation quality?

Details up front: CPC · Wuhan Wansheng Biotechnology.

These are treated as interchangeable and I do not think they are.

If both are acceptable I would like to know that, so I can stop thinking about it.

What is the actual trade-off, and does it matter at the scale I am working at?

This is the question where methodology matters more than the conclusion.

Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.

Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.

The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.

No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.

One laboratory, one method, one submission. Otherwise it is not a comparison.

Start by asking what you are optimising for, because cost per milligram, documentation depth and lead time do not have a common winner.

Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.

Mechanically, cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.

Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.

Use a fixed documentation checklist rather than an impression.

edited 31 Dec 2024 by nadia_kowalczyk — added the citation requested in comments

The honest answer is that most claimed differences between reputable suppliers are inside inter-laboratory noise.

Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.

Nothing here is medical advice, and research-use compounds are not approved for human use.

Price per milligram of measured peptide, not per milligram of label claim.

The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.

To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.

Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.

Compare content, not purity. Purity clusters and content does not.

edited 31 Dec 2024 by kwn_analytical — clarified the distinction between purity and content